The ministry noted that research began on June 17. The vaccine was developed by the Research Center for Epidemiology and Microbiology. N.F. Gamalei.
“Studies of two forms of the vaccine: liquid and lyophilized will be carried out in two medical institutions in Moscow,” the Ministry of Health said.
It is indicated that the vaccine in the form of a solution for intramuscular administration will be examined in a military hospital named after N.N. Burdenko.
In this case, another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, will be tested at Sechenovskiy University.
Earlier, the Russian Ministry of Defense reported that, together with the Gamalea center, it is starting to test human coronavirus vaccines.